- Home
- PMTS vs CERS Comparison
PMTS vs CERS Comparison
Compare PMTS & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- CERS
- Stock Information
- Founded
- PMTS 2007
- CERS 1991
- Country
- PMTS United States
- CERS United States
- Employees
- PMTS N/A
- CERS N/A
- Industry
- PMTS Finance Companies
- CERS EDP Services
- Sector
- PMTS Finance
- CERS Technology
- Exchange
- PMTS Nasdaq
- CERS Nasdaq
- Market Cap
- PMTS 332.0M
- CERS 324.3M
- IPO Year
- PMTS 2015
- CERS 1997
- Fundamental
- Price
- PMTS $35.04
- CERS $1.66
- Analyst Decision
- PMTS Strong Buy
- CERS Buy
- Analyst Count
- PMTS 4
- CERS 3
- Target Price
- PMTS $34.00
- CERS $3.17
- AVG Volume (30 Days)
- PMTS 43.2K
- CERS 979.6K
- Earning Date
- PMTS 11-05-2024
- CERS 10-30-2024
- Dividend Yield
- PMTS N/A
- CERS N/A
- EPS Growth
- PMTS N/A
- CERS N/A
- EPS
- PMTS 1.30
- CERS N/A
- Revenue
- PMTS $458,377,000.00
- CERS $176,229,000.00
- Revenue This Year
- PMTS $9.16
- CERS $26.47
- Revenue Next Year
- PMTS $7.71
- CERS $11.48
- P/E Ratio
- PMTS $26.43
- CERS N/A
- Revenue Growth
- PMTS N/A
- CERS 14.71
- 52 Week Low
- PMTS $15.00
- CERS $1.38
- 52 Week High
- PMTS $34.90
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- PMTS 69.64
- CERS 45.03
- Support Level
- PMTS $33.19
- CERS $1.76
- Resistance Level
- PMTS $34.90
- CERS $1.83
- Average True Range (ATR)
- PMTS 1.33
- CERS 0.09
- MACD
- PMTS -0.06
- CERS -0.01
- Stochastic Oscillator
- PMTS 80.82
- CERS 5.56
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.